ブレインヘルスサプリメントの世界市場：市場規模・シェア分析 - 動向、促進要因、競合情勢、予測 (2024～2030年)

市場概要

世界のブレインヘルスサプリメントの市場規模は、2023年に92億3,820万米ドルに達した後、2024～2030年のCAGRは8.4%で推移し、2030年には161億1,390万米ドルに達すると予測されます。人々がこれを必需品と認識するにつれて、注意力や記憶力の強化、ストレス管理 (特に高齢者) に使用される各種健康補助食品への需要が高まり、市場の成長を後押ししています。

主な洞察

予測期間中、ハーブエキス (イチョウ葉、クルクミン、高麗人参、緑茶エキスなど) のカテゴリーは8.7%のCAGRで進むと予測されています。中国やインドなどの新興国では、ハーブアイテムのニーズが高まっています。

天然分子のカテゴリーは、2023年には世界の収益額の55%を占め、第2位となりました。非合成サプリメントに対する需要の高まりは、合成サプリメントと比較して顕著です。企業は、消費者の圧力の結果として、製品に組み込まれた天然成分を指向しています。

2023年には、記憶力強化のカテゴリーが約30%という最大の収益シェアを生み出しました。一方、2番目に急成長しているカテゴリーは、ストレス・不安症です。

2023年、北米地域の業界シェアは50%でした。これは、認知健康への関心の高まりと堅調なスポーツ分野によるものでした。また、アジア太平洋は脳の健康への懸念、ストレス、教育セクターの需要に牽引され、9.0%以上の成長が見込まれます。

当レポートでは、世界のブレインヘルスサプリメントの市場について分析し、市場の基本構造・最新情勢や主な促進・抑制要因、世界全体および地域別・主要国の市場規模の動向見通し (金額ベース、2017～2030年)、製品別・用途別の詳細動向、現在の市場競争の状況、主要企業のプロファイルなどを調査しております。

目次

第1章 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場指標

第5章 業界の展望

• 市場力学
  • 動向
  • 促進要因
  • 抑制要因/課題
  • 促進要因/抑制要因の影響分析
• 新型コロナウイルス感染症 (COVID-19) の影響
• ポーターのファイブフォース分析

第6章 世界市場

• 概要
• 市場収益：製品別 (2017～2030年)
• 市場収益：用途別 (2017～2030年)
• 市場収益：地域別 (2017～2030年)

第7章 北米市場

• 概要
• 市場収益：製品別 (2017～2030年)
• 市場収益：用途別 (2017～2030年)
• 市場収益：国別 (2017～2030年)

第8章 欧州市場

第9章 アジア太平洋市場

第10章 ラテンアメリカ市場

第11章 中東・アフリカ市場

第12章 米国市場

• 概要
• 市場収益：製品別 (2017～2030年)
• 市場収益：用途別 (2017～2030年)

第13章 カナダ市場

第14章 ドイツ市場

第15章 フランス市場

第16章 英国市場

第17章 イタリア市場

第18章 スペイン市場

第19章 日本市場

第20章 中国市場

第21章 インド市場

第22章 オーストラリア市場

第23章 韓国市場

第24章 ブラジル市場

第25章 メキシコ市場

第26章 サウジアラビア市場

第27章 南アフリカ市場

第28章 アラブ首長国連邦 (UAE) 市場

第29章 競合情勢

• 市場参入企業とその提供品目の一覧
• 主要企業の競合ベンチマーク
• 主要企業の製品ベンチマーク
• 最近の戦略的展開

第30章 企業プロファイル

• AlternaScript LLC
• Natrol LLC
• Health Via Modern Nutrition Inc.
• KeyView Labs Inc.
• Natural Factors Nutritional Products Ltd.
• Onnit Labs Inc.
• Peak Nootropics LLC
• Purelife Bioscience Co. Ltd.
• Intelligent Labs
• Accelerated Intelligence Inc.
• NOW Foods

第31章 付録

Market Overview

The global brain health supplements market size was USD 9,238.2 million in 2023, and it is expected to reach USD 16,113.9 million by 2030, advancing with a CAGR of 8.4% during 2024-2030. As people realize this as a necessity, increasing demand for various health supplements used for attention and memory enhancement and to manage stress (especially in the elderly) is pushing the market growth.

However, beliefs matter in the layout of food and vitamin substances landscaping as it is growing more and more popular with the global community. People who are aware of the healthy way of tom revealing vegan habits are using those who can take plant-based omega-3 dietary supplements. According to Shanna Peevey, the director of consumer research, some sevenfold increase in people's interest in veganism has been registered during the last five to six years.

World Health Organization report points out that the number of people aged 60 and above will more than double between the 2015-2050 periods which was 12% at the beginning to 22% at the end. While older people can sometimes have depressive disorders, they tend to develop more memory loss, for example, Alzheimer's, migraine, Parkinson's, insomnia, and other conditions associated with the brain cells. Alzheimer's consists of diverse symptoms such as memory loss and speech impairment.

Key Insights

During the projection period, the herbal extracts category is projected to advance at 8.7% CAGR.

Comprises ingredients such as ginkgo biloba, curcumin, ginseng, and green tea extract.

Improves memory, brain blood flow, and cognitive function, and decreases mental fatigue.

Increasing need in emerging nations such as China and India for herbal items.

Ancient Chinese medication supplements are also marketed in Western markets.

Vitamins and minerals category to grow significantly, vital for brain function.

Offers B1, B2, B9, omega-3, necessary for neural function, headache reduction, brain wellness, and mood. Usually added into multivitamins.

The natural molecules category stood second in 2023 with 55% of the global revenue generated.

The rising demand for non-synthetic supplements compares with synthetic ones.

Companies are oriented towards natural ingredients embedded into products as a result of consumer pressure.

In 2023, the memory enhancement category generated the largest revenue share of around 30%.

The cause of this alarming rise is more susceptibility to mental health, such as dementia and Alzheimer's disease.

WHO reports that one in every four people has dementia, which is projected to reach 78 million by 2030.

The category Stress & anxiety that is the second fastest growing is the second

The statistical figure almost 3 out of 10 aged 13 to 18 will be diagnosed with an anxiety disorder.

The expected compound growth rate for depression and mood disorders is 8.9% in 2023.

A greater number of cases of depression, in particular vulnerable elders.

In 2023, the North American region had a 50% industry share because of growing cognitive health concerns and a robust sports sector.

Europe anticipates significant growth driven by mental well-being awareness and rising Alzheimer's cases.

APAC expects over 9.0% growth, led by concerns about brain health, stress, and education sector demand.

Table of Contents

Chapter 1. Research Scope

• 1.1. Research Objectives
• 1.2. Market Definition
• 1.3. Analysis Period
• 1.4. Market Size Breakdown by Segments
  • 1.4.1. Market size breakdown, by product
  • 1.4.2. Market size breakdown, by application
  • 1.4.3. Market size breakdown, by region
  • 1.4.4. Market size breakdown, by country
• 1.5. Market Data Reporting Unit
  • 1.5.1. Value
• 1.6. Key Stakeholders

Chapter 2. Research Methodology

• 2.1. Secondary Research
  • 2.1.1. Paid
  • 2.1.2. Unpaid
  • 2.1.3. P&S Intelligence database
• 2.2. Primary Research
• 2.3. Market Size Estimation
• 2.4. Data Triangulation
• 2.5. Currency Conversion Rates
• 2.6. Assumptions for the Study
• 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

• 5.1. Market Dynamics
  • 5.1.1. Trends
  • 5.1.2. Drivers
  • 5.1.3. Restraints/challenges
  • 5.1.4. Impact analysis of drivers/restraints
• 5.2. Impact of COVID-19
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Bargaining power of buyers
  • 5.3.2. Bargaining power of suppliers
  • 5.3.3. Threat of new entrants
  • 5.3.4. Intensity of rivalry
  • 5.3.5. Threat of substitutes

Chapter 6. Global Market

• 6.1. Overview
• 6.2. Market Revenue, by Product (2017-2030)
• 6.3. Market Revenue, by Application (2017-2030)
• 6.4. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

• 7.1. Overview
• 7.2. Market Revenue, by Product (2017-2030)
• 7.3. Market Revenue, by Application (2017-2030)
• 7.4. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

• 8.1. Overview
• 8.2. Market Revenue, by Product (2017-2030)
• 8.3. Market Revenue, by Application (2017-2030)
• 8.4. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

• 9.1. Overview
• 9.2. Market Revenue, by Product (2017-2030)
• 9.3. Market Revenue, by Application (2017-2030)
• 9.4. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

• 10.1. Overview
• 10.2. Market Revenue, by Product (2017-2030)
• 10.3. Market Revenue, by Application (2017-2030)
• 10.4. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

• 11.1. Overview
• 11.2. Market Revenue, by Product (2017-2030)
• 11.3. Market Revenue, by Application (2017-2030)
• 11.4. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

• 12.1. Overview
• 12.2. Market Revenue, by Product (2017-2030)
• 12.3. Market Revenue, by Application (2017-2030)

Chapter 13. Canada Market

• 13.1. Overview
• 13.2. Market Revenue, by Product (2017-2030)
• 13.3. Market Revenue, by Application (2017-2030)

Chapter 14. Germany Market

• 14.1. Overview
• 14.2. Market Revenue, by Product (2017-2030)
• 14.3. Market Revenue, by Application (2017-2030)

Chapter 15. France Market

• 15.1. Overview
• 15.2. Market Revenue, by Product (2017-2030)
• 15.3. Market Revenue, by Application (2017-2030)

Chapter 16. U.K. Market

• 16.1. Overview
• 16.2. Market Revenue, by Product (2017-2030)
• 16.3. Market Revenue, by Application (2017-2030)

Chapter 17. Italy Market

• 17.1. Overview
• 17.2. Market Revenue, by Product (2017-2030)
• 17.3. Market Revenue, by Application (2017-2030)

Chapter 18. Spain Market

• 18.1. Overview
• 18.2. Market Revenue, by Product (2017-2030)
• 18.3. Market Revenue, by Application (2017-2030)

Chapter 19. Japan Market

• 19.1. Overview
• 19.2. Market Revenue, by Product (2017-2030)
• 19.3. Market Revenue, by Application (2017-2030)

Chapter 20. China Market

• 20.1. Overview
• 20.2. Market Revenue, by Product (2017-2030)
• 20.3. Market Revenue, by Application (2017-2030)

Chapter 21. India Market

• 21.1. Overview
• 21.2. Market Revenue, by Product (2017-2030)
• 21.3. Market Revenue, by Application (2017-2030)

Chapter 22. Australia Market

• 22.1. Overview
• 22.2. Market Revenue, by Product (2017-2030)
• 22.3. Market Revenue, by Application (2017-2030)

Chapter 23. South Korea Market

• 23.1. Overview
• 23.2. Market Revenue, by Product (2017-2030)
• 23.3. Market Revenue, by Application (2017-2030)

Chapter 24. Brazil Market

• 24.1. Overview
• 24.2. Market Revenue, by Product (2017-2030)
• 24.3. Market Revenue, by Application (2017-2030)

Chapter 25. Mexico Market

• 25.1. Overview
• 25.2. Market Revenue, by Product (2017-2030)
• 25.3. Market Revenue, by Application (2017-2030)

Chapter 26. Saudi Arabia Market

• 26.1. Overview
• 26.2. Market Revenue, by Product (2017-2030)
• 26.3. Market Revenue, by Application (2017-2030)

Chapter 27. South Africa Market

• 27.1. Overview
• 27.2. Market Revenue, by Product (2017-2030)
• 27.3. Market Revenue, by Application (2017-2030)

Chapter 28. U.A.E. Market

• 28.1. Overview
• 28.2. Market Revenue, by Product (2017-2030)
• 28.3. Market Revenue, by Application (2017-2030)

Chapter 29. Competitive Landscape

• 29.1. List of Market Players and their Offerings
• 29.2. Competitive Benchmarking of Key Players
• 29.3. Product Benchmarking of Key Players
• 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

• 30.1. AlternaScript LLC
  • 30.1.1. Business overview
  • 30.1.2. Product and service offerings
  • 30.1.3. Key financial summary
• 30.2. Natrol LLC
  • 30.2.1. Business overview
  • 30.2.2. Product and service offerings
  • 30.2.3. Key financial summary
• 30.3. Health Via Modern Nutrition Inc.
  • 30.3.1. Business overview
  • 30.3.2. Product and service offerings
  • 30.3.3. Key financial summary
• 30.4. KeyView Labs Inc.
  • 30.4.1. Business overview
  • 30.4.2. Product and service offerings
  • 30.4.3. Key financial summary
• 30.5. Natural Factors Nutritional Products Ltd.
  • 30.5.1. Business overview
  • 30.5.2. Product and service offerings
  • 30.5.3. Key financial summary
• 30.6. Onnit Labs Inc.
  • 30.6.1. Business overview
  • 30.6.2. Product and service offerings
  • 30.6.3. Key financial summary
• 30.7. Peak Nootropics LLC
  • 30.7.1. Business overview
  • 30.7.2. Product and service offerings
  • 30.7.3. Key financial summary
• 30.8. Purelife Bioscience Co. Ltd.
  • 30.8.1. Business overview
  • 30.8.2. Product and service offerings
  • 30.8.3. Key financial summary
• 30.9. Intelligent Labs
  • 30.9.1. Business overview
  • 30.9.2. Product and service offerings
  • 30.9.3. Key financial summary
• 30.10. Accelerated Intelligence Inc.
  • 30.10.1. Business overview
  • 30.10.2. Product and service offerings
  • 30.10.3. Key financial summary
• 30.11. NOW Foods
  • 30.11.1. Business overview
  • 30.11.2. Product and service offerings
  • 30.11.3. Key financial summary

Chapter 31. Appendix

• 31.1. Abbreviations
• 31.2. Sources and References
• 31.3. Related Reports